Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
29 December 1978Website:
http://www.danaher.comNext earnings report:
22 October 2024Last dividends:
28 June 2024Next dividends:
27 September 2024Price
after hours | Wed, 25 Sep 2024 23:48:13 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
DHR Latest News
I maintain my 'Strong Buy' recommendation for Danaher, setting a one-year price target of $310 per share due to improvements in bioprocessing and increased market share in molecular testing. The bioprocessing sector is experiencing strong growth in orders, particularly with a recovery in China, and this trend is likely to continue into Q3 and FY25. Additionally, Cepheid's recent market share gains in molecular testing, such as the FDA approval for its Hepatitis C RNA test, showcase Danaher's potential for innovation and growth.
On September 19, 2024, Danaher Corporation (NYSE: DHR) announced that it will stream its earnings conference call for the third quarter of 2024. This event is scheduled for Tuesday, October 22, 2024, starting at 8:00 a.m.
BREA, California, and TEL AVIV, Israel, in September.
DHR is experiencing strong growth in its Diagnostics division. However, rising costs are still a worry.
On September 4, 2024, in Washington, Danaher Corporation (NYSE: DHR) announced that it is maintaining its earlier forecasts for the third quarter and the entire year of 2024, just before an analyst event that was already planned.
On September 5, 2024, Danaher Corporation (NYSE: DHR) will hold a live video webcast for its Diagnostics Investor and Analyst Meeting in Washington, D.C. The event is set to start around 10:00 a.m.
Danaher's high valuation and flat earnings growth for 2024 may surprise some, but its strong history, smart acquisitions, and potential for long-term growth make it a good investment for those who can afford it. Even though it trades at a high price, Danaher's efficient operations and the possibility of significant earnings growth in 2025 make it one of the few stocks I'm willing to buy at this level. I am increasing my investment in Danaher, anticipating strong returns as growth accelerates, despite its high price-to-earnings ratio.
Danaher (DHR) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
Danaher (DHR) is doing well thanks to its strong clinical diagnostics division, the acquisition of Abcam, and supportive policies for investors. However, there are worries about the weaker performance of its Instrument unit.
Market corrections occur with nearly every president, and stock performance isn't linked to political parties. Right now, inflation is the main factor affecting the market. It's better to invest steadily in strong stocks rather than trying to predict market changes, and we have three key stocks in our portfolios that show resilience and growth potential, providing both dividend growth and value even in tough market conditions.
What type of business is Danaher?
Danaher Corporation is a global diversified conglomerate, one of the world leaders in scientific research and development, and production of innovative products and solutions for multiple industries. Founded in 1969 as an investment fund, it has since undergone a series of transformations (mergers and acquisitions). Today, the company develops, manufactures, and sells professional, medical, industrial, and commercial products and services, characterized by strong brands, innovative technologies, and leading market positions. Danaher's headquarters is located in Washington. Research, manufacturing, sales, service, and administrative centers are located in more than 60 countries - in Europe, Asia, South and North America, and Australia.
What sector is Danaher in?
Danaher is in the Healthcare sector
What industry is Danaher in?
Danaher is in the Diagnostics & Research industry
What country is Danaher from?
Danaher is headquartered in United States
When did Danaher go public?
Danaher initial public offering (IPO) was on 29 December 1978
What is Danaher website?
https://www.danaher.com
Is Danaher in the S&P 500?
Yes, Danaher is included in the S&P 500 index
Is Danaher in the NASDAQ 100?
No, Danaher is not included in the NASDAQ 100 index
Is Danaher in the Dow Jones?
No, Danaher is not included in the Dow Jones index
When was Danaher the previous earnings report?
No data
When does Danaher earnings report?
The next expected earnings date for Danaher is 22 October 2024